Even after adjusting for variables in Model 3 plus HbA1c, systolic blood pressure (BP), lipid parameters, uric acid, eGFR, UAE, smoking status, use of insulin therapy, use of angiotensin-converting enzyme (ACE) inhibitors and/or angiotensin II receptor blockers (ARBs), use of statins, use of anti-platelet agents, and presence of diabetic retinopathy (Model 4), the associations between the FLP-CGM-derived metrics of mean glucose, SD, CV, MAGE, TIR 3.9–10 mmol/L, TAR > 10 mmol/L, TAR > 13.9 mmol/L, TBR < 3.9 mmol/L, TBR < 3.0 mmol/L, and HBGI and baPWV remained significant (Table 2). This evidence concerns the gene INS and diabetic retinopathy.